Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2008, Article ID 237185, 6 pages
http://dx.doi.org/10.1155/2008/237185
Clinical Study

Nicotine Enemas for Active Crohn's Colitis: An Open Pilot Study

1Department of Gastroenterology, Cardiff and Vale NHS Trust, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK
2St Mary's Pharmaceutical Unit, Quadrant Centre, Cardiff Business Park, Llanishen, Cardiff CF14 5RA, UK

Received 7 November 2007; Accepted 19 February 2008

Academic Editor: Julian Walters

Copyright © 2008 J. R. Ingram et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. D. Harries, A. Baird, and J. Rhodes, “Non-smoking: a feature of ulcerative colitis,” British Medical Journal, vol. 284, no. 6317, 706 pages, 1982. View at Google Scholar
  2. H. Jick and A. M. Walker, “Cigarette smoking and ulcerative colitis,” New England Journal of Medicine, vol. 308, no. 5, pp. 261–263, 1983. View at Google Scholar
  3. E. J. Boyko, T. D. Koepsell, D. R. Perera, and T. S. Inui, “Risk of ulcerative colitis among former and current cigarette smokers,” New England Journal of Medicine, vol. 316, no. 12, pp. 707–710, 1987. View at Google Scholar
  4. B. M. Calkins, “A meta-analysis of the role of smoking in inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 34, no. 12, pp. 1841–1854, 1989. View at Publisher · View at Google Scholar
  5. K. W. Somerville, R. F. Logan, M. Edmond, and M. J. Langman, “Smoking and Crohn's disease,” British Medical Journal, vol. 289, no. 6450, pp. 954–956, 1984. View at Google Scholar
  6. L. R. Sutherland, S. Ramcharan, H. Bryant, and G. Fick, “Effect of cigarette smoking on recurrence of Crohn's disease,” Gastroenterology, vol. 98, no. 5, part 1, pp. 1123–1128, 1990. View at Google Scholar
  7. A. J. Wakefield, A. P. Dhillon, P. M. Rowles et al., “Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction,” The Lancet, vol. 334, no. 8671, pp. 1057–1062, 1989. View at Publisher · View at Google Scholar
  8. J.-P. Hugot, M. Chamaillard, H. Zouali et al., “Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease,” Nature, vol. 411, no. 6837, pp. 599–603, 2001. View at Publisher · View at Google Scholar
  9. K. Matsunaga, T. W. Klein, H. Friedman, and Y. Yamamoto, “Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine,” Journal of Immunology, vol. 167, no. 11, pp. 6518–6524, 2001. View at Google Scholar
  10. Y. Geng, S. M. Savage, S. Razani-Boroujerdi, and M. L. Sopori, “Effects of nicotine on the immune response: II. Chronic nicotine treatment induces T cell anergy,” Journal of Immunology, vol. 156, no. 7, pp. 2384–2390, 1996. View at Google Scholar
  11. J. T. Green, H. C. McKirdy, J. Rhodes, G. A. O. Thomas, and B. K. Evans, “Intra-luminal nicotine reduces smooth muscle tone and contractile activity in the distal large bowel,” European Journal of Gastroenterology & Hepatology, vol. 11, no. 11, pp. 1299–1304, 1999. View at Publisher · View at Google Scholar
  12. J. McGrath, J. W. D. McDonald, and J. K. Macdonald, “Transdermal nicotine for induction of remission in ulcerative colitis,” Cochrane Database of Systematic Reviews, vol. 18, no. 4, 2004. View at Google Scholar
  13. R. D. Pullan, J. Rhodes, S. Ganesh et al., “Transdermal nicotine for active ulcerative colitis,” The New England Journal of Medicine, vol. 330, no. 12, pp. 811–815, 1994. View at Publisher · View at Google Scholar
  14. W. J. Sandborn, W. J. Tremaine, K. P. Offord et al., “Transdermal nicotine for mildly to moderately active ulcerative colitis, a randomised, double-blind, placebo-controlled trial,” Annals of Internal Medicine, vol. 126, no. 5, pp. 364–371, 1997. View at Google Scholar
  15. J. T. Green, G. A. O. Thomas, J. Rhodes et al., “Nicotine enemas for active ulcerative colitis—a pilot study,” Alimentary Pharmacology & Therapeutics, vol. 11, no. 5, pp. 859–863, 1997. View at Publisher · View at Google Scholar
  16. W. J. Sandborn, W. J. Tremaine, J. A. Leighton et al., “Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study,” Alimentary Pharmacology & Therapeutics, vol. 11, no. 4, pp. 663–671, 1997. View at Publisher · View at Google Scholar
  17. J. R. Ingram, G. A. O. Thomas, J. Rhodes et al., “A randomized trial of nicotine enemas for active ulcerative colitis,” Clinical Gastroenterology and Hepatology, vol. 3, no. 11, pp. 1107–1114, 2005. View at Publisher · View at Google Scholar
  18. J. R. Ingram, J. Rhodes, B. K. Evans, and G. A. O. Thomas, “Preliminary observations of oral nicotine therapy for inflammatory bowel disease: an open-label phase I-II study of tolerance,” Inflammatory Bowel Diseases, vol. 11, no. 12, pp. 1092–1096, 2005. View at Publisher · View at Google Scholar
  19. J. E. Lennard-Jones, “Classification of inflammatory bowel disease,” Scandinavian Journal of Gastroenterology, vol. 24, supplement 170, pp. 2–6, 1989. View at Publisher · View at Google Scholar
  20. J. T. Green, J. Rhodes, G. A. O. Thomas et al., “Nicotine carbomer enemas—pharmacokinetics of a revised formulation,” Italian Journal of Gastroenterology and Hepatology, vol. 30, no. 3, pp. 260–265, 1998. View at Google Scholar
  21. E. J. Irvine, Q. Zhou, and A. K. Thompson, “The short inflammatory bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT investigators. Canadian Crohn's relapse prevention trial,” American Journal of Gastroenterology, vol. 91, no. 8, pp. 1571–1578, 1996. View at Google Scholar
  22. W. R. Best, J. M. Becktel, J. W. Singleton, and F. Kern Jr., “Development of a Crohn's disease activity index. National cooperative Crohn's disease study,” Gastroenterology, vol. 70, no. 3, pp. 439–444, 1976. View at Google Scholar
  23. A. P. Dick, M. J. Grayson, R. G. Carpenter, and A. Petrie, “Controlled trial of sulphasalazine in the treatment of ulcerative colitis,” Gut, vol. 5, pp. 437–442, 1964. View at Publisher · View at Google Scholar
  24. S. C. Truelove and W. C. D. Richards, “Biopsy studies in ulcerative colitis,” British Medical Journal, vol. 1, no. 4979, pp. 1315–1321, 1956. View at Google Scholar
  25. C. Gasche, J. Scholmerich, J. Brynskov et al., “A simple classification of Crohn's disease: report of the working party for the World Congresses of Gastroenterology, Vienna 1998,” Inflammatory Bowel Diseases, vol. 6, no. 1, pp. 8–15, 2000. View at Google Scholar
  26. J. T. Green, C. Richardson, R. W. Marshall et al., “Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis,” Alimentary Pharmacology & Therapeutics, vol. 14, no. 11, pp. 1429–1434, 2000. View at Publisher · View at Google Scholar
  27. T. T. MacDonald, P. Hutchings, M. Y. Choy, S. Murch, and A. Cooke, “Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine,” Clinical and Experimental Immunology, vol. 81, no. 2, pp. 301–305, 1990. View at Google Scholar
  28. H. Wang, M. Yu, M. Ochani et al., “Nicotinic acetylcholine receptor a7 subunit is an essential regulator of inflammation,” Nature, vol. 421, no. 6921, pp. 384–388, 2003. View at Publisher · View at Google Scholar